EUR/USD 1.1655 ▼ 0.08%GBP/USD 1.3630 ▼ 0.01%USD/JPY 159.3080 ▲ 0.13%USD/CHF 0.8037 ▲ 0.14%EUR/CHF 0.9369 ▲ 0.08%BTC/USD 80,294.16 ▲ 1.65%ETH/USD 2,503.78 ▲ 0.86%SOL/USD 101.32 ▲ 2.37%XAU/USD 4,628.43 ▼ 0.51%EUR/USD 1.1655 ▼ 0.08%GBP/USD 1.3630 ▼ 0.01%USD/JPY 159.3080 ▲ 0.13%USD/CHF 0.8037 ▲ 0.14%EUR/CHF 0.9369 ▲ 0.08%BTC/USD 80,294.16 ▲ 1.65%ETH/USD 2,503.78 ▲ 0.86%SOL/USD 101.32 ▲ 2.37%XAU/USD 4,628.43 ▼ 0.51%
Finance Review DailyMARKETS • BUSINESS • ECONOMY
BREAKING
U.S. Treasury to widen secondary sanctions on Iran, source says•Callan JMB names Michael Reger president of Callan Power unit•Tom Lee's Bitmine buys $81 million of ETH in largest weekly haul since July•Wall Street set for modest losses as Iran tensions, Fed meeting loom•Dream Finders Homes director buys $7,390 in company shares•U.S. Treasury to widen secondary sanctions on Iran, source says•Callan JMB names Michael Reger president of Callan Power unit•Tom Lee's Bitmine buys $81 million of ETH in largest weekly haul since July•Wall Street set for modest losses as Iran tensions, Fed meeting loom•Dream Finders Homes director buys $7,390 in company shares•
ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Markets/ForexArticle

HCW Biologics advances cancer therapies with TGF-β/IL-15 fusion

The biotech firm reports progress in developing a novel fusion protein for cancer treatment.

SL
Sophie Laurent · FX & Rates Desk · 25 Aug 2026 · 14:23 · 1 min read
Share
HCW Biologics advances cancer therapies with TGF-β/IL-15 fusion

HCW Biologics has announced advancements in its cancer therapy pipeline using a TGF-β/IL-15 fusion protein. The development aims to enhance immune responses against tumors.

Euro / US Dollar

EURUSD
Full profile →
1.1674▲ 0.00%
As of 25/08/2026, 09:38:58

Further verified details about clinical trials or regulatory steps were not immediately available.

Healthcare
This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
SL
Written by
Sophie Laurent
FX & Rates Desk

Sophie covers currency markets and central bank policy across Europe, with a focus on how rate decisions ripple through FX pairs. She has been tracking the ECB's policy path since the start of the current easing cycle.

More from Sophie Laurent →
ADVERTISEMENT

Market Snapshot

Delayed
EUR/USD1.1655▼ 0.08%GBP/USD1.3630▼ 0.01%USD/CHF0.8037▲ 0.14%BTC/USD80,294.16▲ 1.65%ETH/USD2,503.78▲ 0.86%XAU/USD4,628.43▼ 0.51%

Related Reading

Celesa to present deupirfenidone trial data at ERS Congress 2026
Forex

Celesa to present deupirfenidone trial data at ERS Congress 2026

Sophie Laurent · 1h ago
ADVERTISEMENT